Vertex Q3 Earnings Preview: What It Means for Your Biotech ETF

Vertex Pharmaceuticals remains a cornerstone holding in several prominent biotechnology exchange-traded funds, making its upcoming Q3 2026 earnings report a critical event for sector-focused portfolios. As the company prepares to disclose its latest financial…